CRISM Therapeutics Statistics

Total Valuation

AIM:CRTX has a market cap or net worth of GBP 7.68 million. The enterprise value is 6.40 million.

Market Cap	7.68M
Enterprise Value	6.40M

Important Dates

The next estimated earnings date is Thursday, June 19, 2025.

Earnings Date	Jun 19, 2025
Ex-Dividend Date	n/a

Share Statistics

AIM:CRTX has 32.68 million shares outstanding. The number of shares has increased by 269.83% in one year.

Current Share Class	32.68M
Shares Outstanding	32.68M
Shares Change (YoY)	+269.83%
Shares Change (QoQ)	n/a
Owned by Insiders (%)	0.54%
Owned by Institutions (%)	n/a
Float	32.50M

Valuation Ratios

PE Ratio	n/a
Forward PE	n/a
PS Ratio	307.17
PB Ratio	5.21
P/TBV Ratio	5.48
P/FCF Ratio	n/a
P/OCF Ratio	n/a
PEG Ratio	n/a

Financial Ratio History

Enterprise Valuation

EV / Earnings	-10.54
EV / Sales	255.89
EV / EBITDA	n/a
EV / EBIT	n/a
EV / FCF	n/a

Financial Position

The company has a current ratio of 4.96

Current Ratio	4.96
Quick Ratio	3.91
Debt / Equity	n/a
Debt / EBITDA	n/a
Debt / FCF	n/a
Interest Coverage	-80.00

Financial Efficiency

Return on equity (ROE) is -135.70% and return on invested capital (ROIC) is -70.02%.

Return on Equity (ROE)	-135.70%
Return on Assets (ROA)	-56.61%
Return on Invested Capital (ROIC)	-70.02%
Return on Capital Employed (ROCE)	-59.66%
Revenue Per Employee	6,250
Profits Per Employee	-151,750
Employee Count	4
Asset Turnover	0.03
Inventory Turnover	n/a

Taxes

Income Tax	n/a
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has increased by +204.83% in the last 52 weeks. The beta is 0.27, so AIM:CRTX's price volatility has been lower than the market average.

Beta (5Y)	0.27
52-Week Price Change	+204.83%
50-Day Moving Average	16.20
200-Day Moving Average	11.21
Relative Strength Index (RSI)	63.03
Average Volume (20 Days)	37,654

Short Selling Information

Short Interest	n/a
Short Previous Month	n/a
Short % of Shares Out	n/a
Short % of Float	n/a
Short Ratio (days to cover)	n/a

Income Statement

In the last 12 months, AIM:CRTX had revenue of GBP 25,000 and -607,000 in losses. Loss per share was -0.02.

Revenue	25,000
Gross Profit	21,000
Operating Income	-880,000
Pretax Income	-593,000
Net Income	-607,000
EBITDA	-864,000
EBIT	-880,000
Loss Per Share	-0.02

Full Income Statement

Balance Sheet

The company has 1.28 million in cash and n/a in debt, giving a net cash position of 1.28 million or 0.04 per share.

Cash & Cash Equivalents	1.28M
Total Debt	n/a
Net Cash	1.28M
Net Cash Per Share	0.04
Equity (Book Value)	1.48M
Book Value Per Share	0.05
Working Capital	1.35M

Full Balance Sheet

Cash Flow

Operating Cash Flow	-933,000
Capital Expenditures	n/a
Free Cash Flow	n/a
FCF Per Share	n/a

Full Cash Flow Statement

Margins

Gross Margin	84.00%
Operating Margin	-3,520.00%
Pretax Margin	-2,372.00%
Profit Margin	n/a
EBITDA Margin	n/a
EBIT Margin	n/a
FCF Margin	n/a

Dividends & Yields

AIM:CRTX does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	-269.83%
Shareholder Yield	n/a
Earnings Yield	-7.90%
FCF Yield	n/a

Dividend Details

Fair Value

There are several formulas that can be used to estimate the intrinsic value of a stock.

Lynch Fair Value	n/a
Lynch Upside	n/a
Graham Number	n/a
Graham Upside	n/a

Stock Splits

The last stock split was on May 31, 2024. It was a reverse split with a ratio of 0.00625.

Last Split Date	May 31, 2024
Split Type	Reverse
Split Ratio	0.00625

Scores

AIM:CRTX has an Altman Z-Score of 2.14 and a Piotroski F-Score of 1. A Z-score under 3 suggests an increased risk of bankruptcy.

Altman Z-Score	2.14
Piotroski F-Score	1